Clinical

South Korea’s Qurient posts phase II success with telacebec in drug-resistant TB

March 27, 2020

HONG KONG – Phase II data of South Korea-based Qurient Co. Ltd.’s novel antibiotic candidate may offer hope that the first universal regimen to treat tuberculosis (TB) regardless of drug resistance status has been found.

Ovarian fever pumps VBL shares, positive peek at phase III cancer gene therapy

March 26, 2020

By Randy Osborne

No Comments

During the conference call on earnings in March, CEO Dror Harats told investors that “the most important thing” about VBL Therapeutics Ltd.’s then-upcoming analysis of interim phase III data with gene therapy VB-111 (ofranergene obadenovec) is that it was “designed in a way that will enable us to tell the market if we are at least as good as what we've seen” in the phase II experiment.

Oncopeptides on track for Q2 NDA for melflufen in myeloma

March 26, 2020

By Cormac Sheridan

No Comments

Oncopeptides AB remains on track for an NDA filing in the second quarter for its peptide-drug conjugate, melflufen, in relapsed refractory multiple myeloma (RRMM).

Genentech moves Actemra into phase III COVID-19 trial

March 24, 2020

By Cormac Sheridan

No Comments

DUBLIN – The Genentech arm of Roche Holding AG plans to move its interleukin-6 inhibitor, Actemra, into a global phase III trial in patients with severe pneumonia associated with COVID-19 infection.

Testing, testing

First repurposing trial for COVID-19 falls flat

March 24, 2020

By Anette Breindl

No Comments

The first attempt at using existing drugs to treat patients infected with SARS-CoV-2 has yielded disappointing results.

Policy advocates propose measures for clinical disruptions in China

March 24, 2020

By Elise Mak and Cornelia Zou

No Comments

BEIJING – China was the first country to face serious disruptions in clinical trials caused by COVID-19, and policy advocates in the country moved quickly to identify lessons for future outbreaks.

Celltrion reaches milestone on COVID-19 super antibody

March 24, 2020

By Gina Lee

No Comments

HONG KONG - Korean biopharma Celltrion Inc. said it’s halfway through the process of creating a super antibody to reign in the COVID-19 novel coronavirus that has claimed almost 13,000 lives globally.

Junshi pushes COVID-19 neutralizing antibodies to clinic; IPO on STAR next

March 24, 2020

By Elise Mak

No Comments

BEIJING – Shanghai Junshi Biosciences Ltd. is developing neutralizing antibodies as a potential treatment for COVID-19, and the program will move on to clinical trials soon. Meanwhile, the biotech is set to launch a pre-revenue IPO on Shanghai’s STAR market.

'MIST' tachycardia endpoint sends Milestone shares to record low

March 24, 2020

By Michael Fitzhugh

No Comments

Despite earlier signs it might meet the primary endpoint of a phase III trial testing its ability to terminate supraventricular tachycardia (SVT) episodes in patients with paroxysmal supraventricular tachycardia (PSVT), a short-acting calcium channel blocker tested by Milestone Pharmaceuticals Inc. failed to do so.

'It's really not going to scale'

Companies face challenges with increasing clinical trial data sources

March 24, 2020

By Brian Orelli

No Comments

A survey of 149 companies by Tufts Center for the Study of Drug Development found more than two-thirds of clinical trial sponsors were using or piloting at least four different data sources in their clinical trials.

Clinical
RSS

South Korea’s Qurient posts phase II success with telacebec in drug-resistant TB

Ovarian fever pumps VBL shares, positive peek at phase III cancer gene therapy

Oncopeptides on track for Q2 NDA for melflufen in myeloma

Genentech moves Actemra into phase III COVID-19 trial

First repurposing trial for COVID-19 falls flat

Policy advocates propose measures for clinical disruptions in China

Celltrion reaches milestone on COVID-19 super antibody

Junshi pushes COVID-19 neutralizing antibodies to clinic; IPO on STAR next

'MIST' tachycardia endpoint sends Milestone shares to record low

Companies face challenges with increasing clinical trial data sources

Popular Stories

South Korea approves first four COVID-19 test kits under urgent-use license

CHF Solutions looks to bring its tech to help COVID-19 patients

Sihuan starts clinical trial of Ebola drug favipiravir for COVID-19

Mallinckrodt to submit IND to FDA for inhaled nitric oxide to treat COVID-19 respiratory distress

Two South Korean COVID-19 kits look overseas, seek FDA approval

BioWorld Premium

Clinical RSS

Popular Stories

BioWorld Premium

Clinical
RSS